Israel Englander’s Embotelladora Andina Series B AKO.B Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-13,827
Closed -$349K 5812
2026
Q1
$349K Buy
+13,827
New +$401K ﹤0.01% 4940
2023
Q3
Sell
-21,930
Closed -$342K 6069
2023
Q2
$342K Buy
+21,930
New +$337K ﹤0.01% 4802
2022
Q4
Sell
-12,420
Closed -$126K 6535
2022
Q3
$126K Sell
12,420
-19,480
-61% -$215K ﹤0.01% 5882
2022
Q2
$355K Buy
+31,900
New +$372K ﹤0.01% 5220
2018
Q4
Sell
-9,953
Closed -$228K 3709
2018
Q3
$228K Buy
+9,953
New +$232K ﹤0.01% 3587
2017
Q3
Sell
-17,103
Closed -$434K 3471
2017
Q2
$434K Buy
+17,103
New +$422K ﹤0.01% 2874
2016
Q2
Sell
-18,842
Closed -$359K 3136
2016
Q1
$359K Sell
18,842
-15,613
-45% -$269K ﹤0.01% 2687
2015
Q4
$600K Buy
34,455
+13,181
+62% +$265K ﹤0.01% 2557
2015
Q3
$441K Buy
+21,274
New +$408K ﹤0.01% 2716
2014
Q4
Sell
-35,342
Closed -$677K 3874
2014
Q3
$677K Buy
35,342
+13,030
+58% +$268K ﹤0.01% 2552
2014
Q2
$505K Buy
+22,312
New +$531K ﹤0.01% 2586

Other funds holding AKO.B

Israel Englander's AKO.B Position: Q2 2026 in Review

Israel Englander sold out of Embotelladora Andina Series B (AKO.B) in Q2 2026, closing a stake of 13,827 shares — an estimated $349K sold.

Israel Englander first reported a position in AKO.B in Q2 2014 and held it in 11 quarters. The position peaked at $677K in Q3 2014. 39 funds tracked by Wall St. Rank hold AKO.B as of Q2 2026.

  • Israel Englander reported no remaining Embotelladora Andina Series B position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 13,827 Embotelladora Andina Series B shares in Q2 2026, an estimated $349K.
  • Israel Englander first reported a position in Embotelladora Andina Series B in Q2 2014 and held it in 11 quarters.
  • Israel Englander's Embotelladora Andina Series B position peaked at $677K in Q3 2014.
  • 39 funds tracked by Wall St. Rank held Embotelladora Andina Series B as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.